EA201291022A1 - Твердая фармацевтическая композиция для нейтрализации желудочной кислоты - Google Patents

Твердая фармацевтическая композиция для нейтрализации желудочной кислоты

Info

Publication number
EA201291022A1
EA201291022A1 EA201291022A EA201291022A EA201291022A1 EA 201291022 A1 EA201291022 A1 EA 201291022A1 EA 201291022 A EA201291022 A EA 201291022A EA 201291022 A EA201291022 A EA 201291022A EA 201291022 A1 EA201291022 A1 EA 201291022A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
neutralization
solid pharmaceutical
gastric acid
alkali metal
Prior art date
Application number
EA201291022A
Other languages
English (en)
Other versions
EA024050B1 (ru
Inventor
Финн Ларсен
Йенс Рихард Педерсен
Original Assignee
С-БИОТЕК ХОЛДИНГ АпС
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by С-БИОТЕК ХОЛДИНГ АпС filed Critical С-БИОТЕК ХОЛДИНГ АпС
Publication of EA201291022A1 publication Critical patent/EA201291022A1/ru
Publication of EA024050B1 publication Critical patent/EA024050B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к фармацевтической композиции, содержащей альгинат щелочного металла, щелочную соль и менее чем % по весу на основе веса альгината щелочного металла соли кальция. Фармацевтическая композиция предназначена для лечения или профилактики диспепсии у млекопитающего.
EA201291022A 2010-04-23 2011-04-18 Твердая фармацевтическая композиция для нейтрализации желудочной кислоты EA024050B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201070167 2010-04-23
US35143710P 2010-06-04 2010-06-04
PCT/DK2011/050125 WO2011131203A2 (en) 2010-04-23 2011-04-18 A solid pharmaceutical composition for neutralizing stomach acid

Publications (2)

Publication Number Publication Date
EA201291022A1 true EA201291022A1 (ru) 2013-09-30
EA024050B1 EA024050B1 (ru) 2016-08-31

Family

ID=44626011

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201291022A EA024050B1 (ru) 2010-04-23 2011-04-18 Твердая фармацевтическая композиция для нейтрализации желудочной кислоты

Country Status (11)

Country Link
US (1) US9186409B2 (ru)
EP (1) EP2560732A2 (ru)
JP (2) JP2013525313A (ru)
KR (1) KR20130091250A (ru)
CN (1) CN102844077A (ru)
AU (1) AU2011242177B8 (ru)
BR (1) BR112012026860A2 (ru)
CA (1) CA2795521A1 (ru)
EA (1) EA024050B1 (ru)
IL (1) IL222625A0 (ru)
WO (1) WO2011131203A2 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2580965B1 (en) 2009-11-26 2018-07-18 D. Xign Limited Appetite regulating dietary supplement
JP6245677B2 (ja) * 2012-01-20 2017-12-13 ニプロ株式会社 口腔内崩壊錠
EP3288556A4 (en) * 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
ITUB20152623A1 (it) * 2015-07-30 2017-01-30 Neilos S R L Composizione per uso orale nel trattamento dei disturbi o malattia da reflusso gastroesofageo
JP6498158B2 (ja) * 2016-07-11 2019-04-10 ニプロ株式会社 口腔内崩壊錠
MX2024000360A (es) * 2021-07-05 2024-04-16 Reflux Gourmet Llc Producto nutricional y auxiliar digestivo de alginato, polilisina y conservante de semillas.

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
GB1566609A (en) * 1977-03-10 1980-05-08 Reckitt & Colmann Prod Ltd Pharmaceutical compositions containing cholestyramine and alginic acid
GB1601833A (en) 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
EP0484106A1 (en) * 1990-11-01 1992-05-06 Merck & Co. Inc. Controlled release formulations
CZ225893A3 (en) * 1991-04-04 1994-04-13 Procter & Gamble Chewing antacid preparation
AU8000494A (en) 1993-10-29 1995-05-22 Reckitt & Colman Products Limited Gelatin capsule fill able to foam
KR970703156A (ko) * 1994-05-24 1997-07-03 원본미기재 고형 제산제 및 이의 제조방법(Solid antacid and process for producing the same)
GB2298365B (en) 1995-03-03 1997-05-07 Reckitt & Colmann Prod Ltd A liquid pharmaceutical composition alginate and potassium bicarbonate
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
GB9708773D0 (en) 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
PL195031B1 (pl) 1997-04-30 2007-08-31 Reckitt Benckiser Healthcare Ciekła wodna kompozycja nadająca się do nalewaniazawierająca alginian i wodorowęglan metalu alkalicznego
GB9812426D0 (en) 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB0012094D0 (en) 2000-05-19 2000-07-12 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
GB2384986B (en) 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
US6703044B1 (en) 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
CA2531065A1 (en) 2003-07-10 2005-01-27 Smithkline Beecham Corporation Pharmaceutical compositions
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
AR056062A1 (es) * 2006-06-05 2007-09-19 Bago Sa Labor Composicion farmaceutica antiacida en forma de polvo, preparacion farmaceutica que la comprende y proceso para su preparacion
DE102006037298A1 (de) 2006-08-08 2008-02-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung, insbesondere Antazidum
GB0814376D0 (en) 2008-08-06 2008-09-10 Reckitt Benckiser Healthcare Formulation

Also Published As

Publication number Publication date
KR20130091250A (ko) 2013-08-16
WO2011131203A3 (en) 2012-09-13
US20130210762A1 (en) 2013-08-15
EP2560732A2 (en) 2013-02-27
JP2013525313A (ja) 2013-06-20
JP2016166220A (ja) 2016-09-15
AU2011242177B8 (en) 2015-06-04
BR112012026860A2 (pt) 2018-06-05
CN102844077A (zh) 2012-12-26
CA2795521A1 (en) 2011-10-27
US9186409B2 (en) 2015-11-17
AU2011242177A1 (en) 2012-10-25
WO2011131203A2 (en) 2011-10-27
EA024050B1 (ru) 2016-08-31
IL222625A0 (en) 2012-12-31
AU2011242177B2 (en) 2015-05-14

Similar Documents

Publication Publication Date Title
EA201291022A1 (ru) Твердая фармацевтическая композиция для нейтрализации желудочной кислоты
PH12014501718A1 (en) Novel therapeutic agents
EA201291357A1 (ru) Способы лечения с применением ингибиторов tlr7 и/или tlr9
CN105693645A8 (zh) 作为离子通道调节剂的稠合杂环化合物
NZ704662A (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201590890A1 (ru) Производные 5-фтор-n-(пиридин-2-ил)пиридин-2-амина, содержащие сульфоксиминовую группу
EA201490458A1 (ru) Способ получения тернесита
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
EA201491766A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EA201490854A1 (ru) Противовирусные соединения
MY161088A (en) Agonists of gpr40
EA201201374A1 (ru) Лечение атаксии-телеангиэктазии
EA201290860A1 (ru) Лечение ревматоидного артрита комбинацией лаквинимода и метотрексата
EA201390081A1 (ru) Дейтерированный n-этил-n-фенил-1,2-дигидро-4-гидрокси-5-хлор-1-метил-2-оксохинолин-3-карбоксамид, его соли и их применение
EA201300053A1 (ru) Фосфатсвязывающий препарат для удобного приема
SG10201811186XA (en) Purification of proteins
EA201101194A1 (ru) Применение розувастатин лактолов в качестве лекарственных препаратов
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
EA201500851A1 (ru) ЭСТРА-1,3,5(10),16-ТЕТРАЕН-3-КАРБОКСАМИДЫ ДЛЯ ИНГИБИРОВАНИЯ 17β-ГИДРОКСИСТЕРОИД-ДЕГИДРОГЕНАЗЫ (AKR1C3)
MX340983B (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
EA201891804A1 (ru) Тетрациклиновые соединения
MY173491A (en) Therapeutic or prophylactic agent for biliary tract diseases

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM BY KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ KZ RU